Delivery Order SPE2DB24D1034-SPE2DB25FWDB2

Award Date 5/20/25
Potential Completion Date 5/21/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SHINGRIX vial kits. The contract has a ceiling value of $1,139.18 and a period of performance through May 15, 2025. The contract is a firm-fixed-price delivery order, and it is not set aside for any specific business category. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SHINGRIX vial kits. The contract has a ceiling value of $1,139.18 and a period of performance through May 7, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive global...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,139.18, is for the delivery of SHINGRIX VIAL KITS, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside arrangement with a performance period through May 1, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of SHINGRIX vial kits. The firm-fixed-price contract has a ceiling value of $11,062.33 and a performance period ending on May 13, 2022. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical valued at up to $999,999,999.00 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of SHINGRIX vial kits, with a ceiling value of $1,139.18 and a period of performance through February 27, 2025. The contract is a firm fixed-price, delivery order type, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,278.36, is for the delivery of SHINGRIX vial kits and has a period of performance through May 5, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of 4,567,926,143 units of SHINGRIX VIAL KITS, with a ceiling value of $64,050.58. The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of SHINGRIX vaccine vials. The contract has a ceiling value of $1,987.36 and an ultimate completion date of August 8, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which provides...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $4,187.16. The contract is for the supply of SHINGRIX vial kits, which are likely vaccines or other medical products. The order has a firm fixed price and a completion date of September 18, 2024. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SHINGRIX VIAL KITS, a pharmaceutical product, with a ceiling value of $6,372.14 and a period of performance through April 11, 2025. The contract is designated as a firm fixed-price delivery order and is not set aside for any specific business category. AmerisourceBergen Drug Corp...
  • SPE2DB24D1034
    Indefinite Delivery Contract
  • SPE2DB24D1034-SPE2DB25FWDB2
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SHINGRIX vial kits. The contract is a firm fixed-price delivery order with a ceiling value of $1,139.18 and a performance period ending on May 21, 2025. AmerisourceBergen Drug Corp is delivering these medical products to support federal agencies, particularly the military and veteran healthcare systems. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle for the DLA Troop Support Medical program through December 2026. The contract is designated as non-set-aside, indicating open competition.

Generated 8/24/25, 1:03 AM